» Articles » PMID: 35155208

Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in PT3a Renal Cell Carcinoma: A Population-Based Study

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Feb 14
PMID 35155208
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the cause-specific survival (CSS) and overall survival (OS) of patients with localized T3a renal cell carcinoma (RCC) after partial nephrectomy (PN) or radical nephrectomy (RN).

Methods: We obtained the demographic and clinicopathological data of 7,127 patients with localized T3a RCC and who underwent PN or RN from the Surveillance, Epidemiology, and End Results (SEER) database. These patients were divided into fat invasion cohort and venous invasion cohort for subsequent analysis. Kaplan-Meier analysis (KMA) and univariate and multivariate Cox proportional hazards regression analyses were used to evaluate the effects of PN or RN on OS and CSS. Meanwhile, 65 cases with clinical T1 (cT1) RCC upstaged to pathological T3a (pT3a) who were treated in Tongji Hospital (TJH) from 2011 to 2020 and underwent PN or RN were identified.

Results: In the study cohort, 2,085 (29.3%) patients died during the 1-172 months' follow-up, of whom 1,155 (16.2%) died of RCC. In the two cohorts of fat invasion and venous invasion, KMA indicated that the PN group had favorable survival ( < 0.001). However, after propensity score matching (PSM), univariate and multivariate Cox regression analyses showed that the PN and RN groups had comparable CSS in the fat invasion cohort ( = 0.075) and the venous invasion cohort ( = 0.190). During 1-104 months of follow-up, 9 cases in the Tongji cohort had disease recurrence. There was no significant difference in recurrence-free survival between the RN group and the PN group ( = 0.170).

Conclusions: Our analysis showed that after balancing these factors, patients with localized pT3a RCC receiving PN or RN can achieve comparable oncologic outcomes. PN is safe for selected T3a patients.

Citing Articles

A clinical audit of adverse post-nephrectomy outcomes in renal cell carcinoma patients at a tertiary hospital in Queensland, Australia.

Chequer de Souza J, Vangaveti V, Biros E, Mallett A J Nephrol. 2025; .

PMID: 39762514 DOI: 10.1007/s40620-024-02173-6.


Editorial: Organ-sparing surgery for genitourinary cancers.

Long G, Xiao X, Liu H, Zhang Y, Yang C Front Oncol. 2024; 14:1443878.

PMID: 39091921 PMC: 11291462. DOI: 10.3389/fonc.2024.1443878.


Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.

Xing Z, Xu H, Ai K, Deng H, Hong Y, Deng P Ann Surg Oncol. 2024; 31(5):3531-3543.

PMID: 38329657 DOI: 10.1245/s10434-024-14958-x.


Evolution in the management of vestibular schwannoma: a single-center 15-year experience.

Ahmad Y, Gallois Y, Sol J, Boetto S, Attal J, Sabatier J Eur Arch Otorhinolaryngol. 2023; 280(11):4885-4894.

PMID: 37195345 DOI: 10.1007/s00405-023-08009-6.


Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1-2M1 renal cell carcinoma.

Tian J, Zeng X, Zhu J, Guan W, Hu Z, Yang C Transl Cancer Res. 2023; 12(2):301-309.

PMID: 36915574 PMC: 10007872. DOI: 10.21037/tcr-22-1389.

References
1.
Lee H, Lee M, Lee S, Byun S, Kim H, Kwak C . Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy. BMC Cancer. 2018; 18(1):427. PMC: 5902926. DOI: 10.1186/s12885-018-4338-1. View

2.
Patel S, Uzzo R, Larcher A, Peyronnet B, Lane B, Pruthi D . Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis. Clin Genitourin Cancer. 2020; 18(6):e723-e729. DOI: 10.1016/j.clgc.2020.05.002. View

3.
Kang H, Lee S, Kim W, Yun S, Lee S, Kim W . Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter study. J Surg Oncol. 2016; 114(1):70-4. DOI: 10.1002/jso.24259. View

4.
Antonelli A, Palumbo C, Sandri M, Veccia A, Furlan M, Zamboni S . Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study. Clin Genitourin Cancer. 2020; 18(4):e360-e367. DOI: 10.1016/j.clgc.2019.12.005. View

5.
Cronin K, Ries L, Edwards B . The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Cancer. 2014; 120 Suppl 23:3755-7. DOI: 10.1002/cncr.29049. View